Stay updated on Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page revision indicator was updated from v3.6.2 to v3.6.3, reflecting a new build of the page.
    Difference
    0.1%
    Check dated 2026-07-03T21:45:50.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page revision tag was updated to v3.6.2, indicating a newer build of the page. No study content or functionality were altered.
    Difference
    0.1%
    Check dated 2026-06-26T20:26:59.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now indicates that the study is completed and no longer looking for participants. Enrollment has closed and no new participants are being sought.
    Difference
    0.5%
    Check dated 2026-06-12T13:23:16.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.5.4 to v3.5.5, indicating a new version of the page or its template. This is a metadata update and does not reflect substantive changes to the study data or content.
    Difference
    0.1%
    Check dated 2026-06-05T10:08:04.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, signalling a platform update. No study data or page content was changed.
    Difference
    0.1%
    Check dated 2026-05-15T05:29:18.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.3, signaling an updated site version. This update does not alter the study’s content or outcomes, and is a backend/version change rather than a content modification.
    Difference
    0.1%
    Check dated 2026-04-30T18:47:26.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in HR-Competent & Deficient Tumors Clinical Trial page.